Anshuman Panda
Overview
Explore the profile of Anshuman Panda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah A, Neitzel E, Panda A, Fananapazir G
Abdom Radiol (NY)
. 2024 Apr;
49(8):2858-2872.
PMID: 38561553
Ferumoxytol is an ultrasmall superparamagnetic iron oxide which has been used as an off-label intravenous contrast agent for MRI. Unlike gadolinium-based contrast agents, ferumoxytol remains in the intravascular space with...
2.
Harwood M, Fahrenholtz S, Wellnitz C, Kawashima A, Panda A
Radiographics
. 2024 Feb;
44(3):e230102.
PMID: 38421911
Active implanted medical devices (AIMDs) enable therapy and patient monitoring by way of electrical activity and typically have a battery and electrical leads. The most common types of AIMDs include...
3.
Zhou Y, Panda A, Jokerst C
J Magn Reson Imaging
. 2022 May;
56(1):246-247.
PMID: 35567592
No abstract available.
4.
Panda A, Betigeri A, Ganesan S
Front Genet
. 2022 Mar;
13:706468.
PMID: 35309122
Immune checkpoint blockade (ICB), therapies that target the PD-1 pathway, CTLA-4 pathway, and other checkpoint pathways, lead to durable responses in many cancer types. Since only a minority of patients...
5.
Panda A, Bhanot G, Ganesan S, Bajpai M
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885081
Esophageal adenocarcinoma (EAC) is strongly associated with Barrett's esophagus (BE), a pre-malignant condition resulting from gastric reflux. Esophageal squamous cell carcinoma (ESCC), the other major subtype of esophageal cancer, shows...
6.
Zhou Y, Jokerst C, Panda A
J Magn Reson Imaging
. 2021 Nov;
55(6):1853-1854.
PMID: 34797000
No abstract available.
7.
Panda A, Shin M, Cheng C, Bajpai M
Front Genet
. 2021 Oct;
12:706706.
PMID: 34603373
Esophageal adenocarcinoma (EA) arises from Barrett's epithelium (BE), and chronic gastroesophageal reflux disease is considered the strongest risk factor for disease progression. All BE patients undergo acid suppressive therapy, surveillance,...
8.
Tong K, Kothari O, Haro K, Panda A, Bandari M, Carrick J, et al.
Oncogene
. 2021 Aug;
40(41):6034-6048.
PMID: 34453124
BRAF-driven colorectal cancer is among the poorest prognosis subtypes of colon cancer. Previous studies suggest that BRAF-mutant serrated cancers frequently exhibit Microsatellite Instability (MSI) and elevated levels of WNT signaling....
9.
Panda A, Ganesan S
Front Genet
. 2021 Aug;
12:706435.
PMID: 34367262
Immune checkpoint blockade leads to unprecedented responses in many cancer types. An alternative method of unleashing anti-tumor immune response is to target immunosuppressive metabolic pathways like the indoleamine 2,3-dioxygenase (IDO)...
10.
Bajpai M, Panda A, Birudaraju K, Van Gurp J, Chak A, Das K, et al.
Front Genet
. 2021 Jun;
12:674741.
PMID: 34178034
Barrett's esophagus (BE) is a premalignant metaplasia in patients with chronic gastroesophageal reflux disease (GERD). BE can progress to esophageal adenocarcinoma (EA) with less than 15% 5-year survival. Chromosomal aneuploidy,...